OBJECTIVE: To support the hypothesis about the potential compensatory role of ipsilateral corticofugal pathways when the contralateral pathways are impaired by brain tumours. METHODS: Retrospective analysis was carried out on the results of functional MRI (fMRI) of a selected group of five paretic patients with Rolandic brain tumours who exhibited an abnormally high ipsilateral/contralateral ratio of activation-that is, movements of the paretic hand activated predominately the ipsilateral cortex. Brain activation was achieved with a flexion extension of the fingers. Statistical parametric activation was obtained using a t test and a threshold of p<0.001. These patients, candidates for tumour resection, also underwent cortical intraoperative stimulation that was correlated to the fMRI spatial data using three dimensional reconstructions of the brain. Three patients also had postoperative control fMRI. RESULTS: The absence of fMRI activation of the primary sensorimotor cortex normally innervating the paretic hand for the threshold chosen, was correlated with completely negative cortical responses of the cortical hand area during the operation. The preoperative fMRI activation of these patients predominantly found in the ipsilateral frontal and primary sensorimotor cortices could be related to the residual ipsilateral hand function. Postoperatively, the fMRI activation returned to more classic patterns of activation, reflecting the consequences of therapy. CONCLUSION: In paretic patients with brain tumours, ipsilateral control could be implicated in the residual hand function, when the normal primary pathways are impaired. The possibility that functional tissue still remains in the peritumorous sensorimotor cortex even when the preoperative fMRI and the cortical intraoperative stimulations are negative, should be taken into account when planning the tumour resection and during the operation.
OBJECTIVE: To support the hypothesis about the potential compensatory role of ipsilateral corticofugal pathways when the contralateral pathways are impaired by brain tumours. METHODS: Retrospective analysis was carried out on the results of functional MRI (fMRI) of a selected group of five pareticpatients with Rolandic brain tumours who exhibited an abnormally high ipsilateral/contralateral ratio of activation-that is, movements of the paretic hand activated predominately the ipsilateral cortex. Brain activation was achieved with a flexion extension of the fingers. Statistical parametric activation was obtained using a t test and a threshold of p<0.001. These patients, candidates for tumour resection, also underwent cortical intraoperative stimulation that was correlated to the fMRI spatial data using three dimensional reconstructions of the brain. Three patients also had postoperative control fMRI. RESULTS: The absence of fMRI activation of the primary sensorimotor cortex normally innervating the paretic hand for the threshold chosen, was correlated with completely negative cortical responses of the cortical hand area during the operation. The preoperative fMRI activation of these patients predominantly found in the ipsilateral frontal and primary sensorimotor cortices could be related to the residual ipsilateral hand function. Postoperatively, the fMRI activation returned to more classic patterns of activation, reflecting the consequences of therapy. CONCLUSION: In pareticpatients with brain tumours, ipsilateral control could be implicated in the residual hand function, when the normal primary pathways are impaired. The possibility that functional tissue still remains in the peritumorous sensorimotor cortex even when the preoperative fMRI and the cortical intraoperative stimulations are negative, should be taken into account when planning the tumour resection and during the operation.
Authors: M D Caramia; S Telera; M G Palmieri; M Wilson-Jones; A Scalise; C Iani; R Giuffrè; G Bernardi Journal: Neurology Date: 1998-07 Impact factor: 9.910
Authors: D J Werring; C A Clark; G J Barker; D H Miller; G J Parker; M J Brammer; E T Bullmore; V P Giampietro; A J Thompson Journal: J Neurol Neurosurg Psychiatry Date: 1998-12 Impact factor: 10.154
Authors: F Z Yetkin; W M Mueller; G L Morris; T L McAuliffe; J L Ulmer; R W Cox; D L Daniels; V M Haughton Journal: AJNR Am J Neuroradiol Date: 1997-08 Impact factor: 3.825
Authors: S R Stapleton; E Kiriakopoulos; D Mikulis; J M Drake; H J Hoffman; R Humphreys; P Hwang; H Otsubo; S Holowka; W Logan; J T Rutka Journal: Pediatr Neurosurg Date: 1997-02 Impact factor: 1.162
Authors: S C Cramer; G Nelles; R R Benson; J D Kaplan; R A Parker; K K Kwong; D N Kennedy; S P Finklestein; B R Rosen Journal: Stroke Date: 1997-12 Impact factor: 7.914
Authors: Giancarlo D'Andrea; Albina Angelini; Andrea Romano; Antonio Di Lauro; Giovanni Sessa; Alessandro Bozzao; Luigi Ferrante Journal: Neurosurg Rev Date: 2012-02-28 Impact factor: 3.042
Authors: Juan Martino; Susanne M Honma; Anne M Findlay; Adrian G Guggisberg; Julia P Owen; Heidi E Kirsch; Mitchel S Berger; Srikantan S Nagarajan Journal: Ann Neurol Date: 2011-03-11 Impact factor: 10.422